UnitedHealth Group Incorporated
—- Market cap
- —
- Debt
- +$78.39B
- Cash
- −$24.37B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: UNH stock price vs NVDA: inconclusive — current versus $503.55 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NVDA's multiple
Implied fair value · at UNH's multiple
Needs UNH P/E.
Close Dec 31, 2025
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 100% equity / 0% debt · EV / Revenue 20.80x · EV proxy / EBITDA proxy 33.72x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
UnitedHealth Group Incorporated · implied price per share
Bear
$222.49
Base
$271.41
Bull
$335.10
NVIDIA CORP · implied price per share
Bear
$43.09
Base
$52.57
Bull
$59.95
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HUMANA INC
UNH vs HUM
CENTENE CORP
UNH vs CNC
CVS Health Corporation
UNH vs CVS
Elevance Health, Inc.
UNH vs ELV
MOLINA HEALTHCARE, INC.
UNH vs MOH
ADVANCED MICRO DEVICES INC
UNH vs AMD
INTEL CORP
UNH vs INTC
TEXAS INSTRUMENTS INC
UNH vs TXN
Broadcom Inc.
UNH vs AVGO
QUALCOMM INC/DE
UNH vs QCOM
MICROCHIP TECHNOLOGY INC
UNH vs MCHP
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe UNH can re-accelerate growth and sustain margin expansion closer to NVDA's quality profile, then consider buying the discount because the current valuation still sits below the implied NVDA price; otherwise, the cheaper multiples alone do not outweigh NVDA's superior growth and profitability.
UNH trades at 31.3x P/E versus NVDA at 38.1x, while also looking far cheaper on P/S, EV/Revenue, and EV/EBITDA. However, NVDA's much higher growth and margin profile justify a structural valuation premium, so the apparent discount is not automatically a bargain signal.
Supporting Metrics